Innovative Industry Payer Agreements Roundtable

Innovative Industry Payer Agreements: Presentations

Sunday, 3 April 2011
Vancouver, British Columbia

Welcome and Opening Remarks

  • John Sproule, Senior Policy Director, Institute of Health Economics
    Chris Henshall, Chair, HTAi Policy Forum

Overview of Survey Findings - Canadian and International Perspectives

International Perspectives - Overview of Issues

Overview of Issues

Reflections and Directed Discussion: Panel 
(The Panel below provided reflections on sessions throughout the day.)

  • Glenn Monteith, Assistant Deputy Minister of Health, Health Workforce Division, Alberta Health and Wellness
    Judith Glennie, Director Strategic Health Technology Assessment, Janssen Inc.
    Newell McElwee, Executive Director US Outcomes Research Group, Merck Co.
    Don Husereau, Independent Consultant, Former Senior Advisor, Canadian Agency for Drugs and Technologies in Health

Experiences, Lessons Learned, and Opportunities for Canada

Payer Perspectives

Reflections and Directed Discussion: Panel

Industry Perspectives

Reflections and Directed Discussion: Panel

Reflective Panel Discussion - Successes, Knowledge Gaps and Policy Development

  • Moderator: Chris Henshall, Chair, HTAi Policy Forum
    Alison Maloney, Director, Health Economics and Reimbursement, AstraZeneca
    Olaf Koester, Drug Plan Director, Drug Management Policy Unit, Manitoba Ministry of Health
    Kevin Leshuk, GM Celgene Inc. (Canadian Biotech)
    Lucie Robitaille, General Director, Le conseil du medicament, Institut national d'excellence en santé et en services sociaux (INNESS)



View videos in album format: